AG真人官方

KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the company will host a live webcast at 8:30 a.m. ET on Thursday, September 11, 2025 to provide an operational update and release financial results for the fiscal quarter ended July 31, 2025.

The webcast can be accessed on the Investors section of the Company鈥檚 website at . A replay will be available for at least 30 days following the event.

About聽KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. In the聽U.S.,听KalVista聽markets EKTERLY^庐, the first and only oral on-demand treatment for hereditary angioedema (HAE). The Company has multiple regulatory applications under review in key global markets. For more information about聽KalVista, please visit聽聽and follow us on聽,听,听听补苍诲听.

View source version on businesswire.com:

Investors:

Ryan Baker

Head, Investor Relations

(617) 771-5001

[email protected]

Media:

Molly Cameron

Director, Corporate Communications

(857) 356-0164

[email protected]

Source: KalVista Pharmaceuticals, Inc.